Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,437 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
TLR Signals in Epithelial Cells in the Nasal Cavity and Paranasal Sinuses.
Suzuki M, Cooksley C, Suzuki T, Ramezanpour M, Nakazono A, Nakamaru Y, Homma A, Vreugde S. Suzuki M, et al. Among authors: suzuki t. Front Allergy. 2021 Nov 22;2:780425. doi: 10.3389/falgy.2021.780425. eCollection 2021. Front Allergy. 2021. PMID: 35387020 Free PMC article. Review.
Nasal manifestations of immunoglobulin G4-related disease.
Suzuki M, Nakamaru Y, Akazawa S, Mizumachi T, Maeda M, Takagi D, Hatanaka KC, Fukuda S. Suzuki M, et al. Laryngoscope. 2013 Apr;123(4):829-34. doi: 10.1002/lary.23792. Epub 2012 Nov 20. Laryngoscope. 2013. PMID: 23168498
Elevated Level of Myeloperoxidase-Deoxyribonucleic Acid Complex in the Middle Ear Fluid Obtained From Patients With Otitis Media Associated With Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
Morita S, Nakamaru Y, Nakazawa D, Hattanda F, Shida H, Kusunoki Y, Watanabe K, Masuda S, Takagi D, Suzuki M, Hoshino K, Fukuda A, Tomaru U, Homma A, Ishizu A. Morita S, et al. Among authors: suzuki m. Otol Neurotol. 2018 Apr;39(4):e257-e262. doi: 10.1097/MAO.0000000000001708. Otol Neurotol. 2018. PMID: 29342044
Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02).
Tahara M, Kiyota N, Yokota T, Hasegawa Y, Muro K, Takahashi S, Onoe T, Homma A, Taguchi J, Suzuki M, Minato K, Yane K, Ueda S, Hara H, Saijo K, Yamanaka T. Tahara M, et al. Among authors: suzuki m. Ann Oncol. 2018 Apr 1;29(4):1004-1009. doi: 10.1093/annonc/mdy040. Ann Oncol. 2018. PMID: 29408977 Free article. Clinical Trial.
15,437 results
You have reached the last available page of results. Please see the User Guide for more information.